These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8000691)
41. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Kalra S; Swystun VA; Bhagat R; Cockcroft DW Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376 [TBL] [Abstract][Full Text] [Related]
42. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma. Kesten S; Chapman KR; Broder I; Cartier A; Hyland RH; Knight A; Malo JL; Mazza JA; Moote DW; Small P Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):622-5. PubMed ID: 1892303 [TBL] [Abstract][Full Text] [Related]
43. Does ketotifen have a steroid-sparing effect in childhood asthma? Canny GJ; Reisman J; Levison H Eur Respir J; 1997 Jan; 10(1):65-70. PubMed ID: 9032494 [TBL] [Abstract][Full Text] [Related]
44. Bronchodilator response to salbutamol after spontaneous recovery from nonspecific bronchial provocation tests in asthma. Polosa R; Prosperini G; Magrì S; Ciamarra I; Pagano C; Paolino G; Santonocito G; Crimi N Eur Respir J; 1998 May; 11(5):1086-90. PubMed ID: 9648960 [TBL] [Abstract][Full Text] [Related]
45. Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma. Lim S; Jatakanon A; John M; Gilbey T; O'connor BJ; Chung KF; Barnes PJ Am J Respir Crit Care Med; 1999 Jan; 159(1):22-30. PubMed ID: 9872813 [TBL] [Abstract][Full Text] [Related]
46. The utility of methacholine airway responsiveness measurements in evaluating anti-asthma drugs. Inman MD; Hamilton AL; Kerstjens HA; Watson RM; O'Byrne PM J Allergy Clin Immunol; 1998 Mar; 101(3):342-8. PubMed ID: 9525450 [TBL] [Abstract][Full Text] [Related]
47. The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours. Derom EY; Pauwels RA; Van der Straeten ME J Allergy Clin Immunol; 1992 Apr; 89(4):811-5. PubMed ID: 1560164 [TBL] [Abstract][Full Text] [Related]
48. Rates of change in peak expiratory flow and in diurnal variation in peak flow in patients recovering from acute severe asthma. Packe GE; Freeman W; Cayton RM Clin Sci (Lond); 1994 Jan; 86(1):59-65. PubMed ID: 8306553 [TBL] [Abstract][Full Text] [Related]
49. Airway responsiveness to methacholine and risk of asthma in patients with allergic rhinitis. Prieto L; Bertó JM; Gutierrez V Ann Allergy; 1994 Jun; 72(6):534-9. PubMed ID: 8203797 [TBL] [Abstract][Full Text] [Related]
50. Which index of peak expiratory flow is most useful in the management of stable asthma? Reddel HK; Salome CM; Peat JK; Woolcock AJ Am J Respir Crit Care Med; 1995 May; 151(5):1320-5. PubMed ID: 7735580 [TBL] [Abstract][Full Text] [Related]
52. Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. The Dutch CNSLD Study Group. Waalkens HJ; Van Essen-Zandvliet EE; Hughes MD; Gerritsen J; Duiverman EJ; Knol K; Kerrebijn KF Am Rev Respir Dis; 1993 Nov; 148(5):1252-7. PubMed ID: 8239161 [TBL] [Abstract][Full Text] [Related]
53. A comparison of regular with intermittent bronchodilators in asthma patients on inhaled steroids. Tormey VJ; Faul J; Leonard C; Lennon A; Burke CM Ir J Med Sci; 1997; 166(4):249-52. PubMed ID: 9394077 [TBL] [Abstract][Full Text] [Related]
54. Correlation of nonspecific bronchial responsiveness to baseline pulmonary function in patients with asthma and sinobronchial syndrome. Fujimura M; Kamio Y; Hashimoto T; Matsuda T Intern Med; 1993 Jan; 32(1):1-5. PubMed ID: 8495036 [TBL] [Abstract][Full Text] [Related]
55. The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease. Bel EH; Zwinderman AH; Timmers MC; Dijkman JH; Sterk PJ Thorax; 1991 Jan; 46(1):9-14. PubMed ID: 1871705 [TBL] [Abstract][Full Text] [Related]
56. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide. de Jong JW; van der Mark TW; Koëter GH; Postma DS Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165 [TBL] [Abstract][Full Text] [Related]
57. Effects of inhaled substance P on airway responsiveness to methacholine in asthmatic subjects in vivo. Cheung D; van der Veen H; den Hartigh J; Dijkman JH; Sterk PJ J Appl Physiol (1985); 1994 Sep; 77(3):1325-32. PubMed ID: 7530706 [TBL] [Abstract][Full Text] [Related]
58. Asthma, bronchial hyperreactivity and mediator release in children with birch pollinosis. ECP and EPX levels are not related to bronchial hyperreactivity. Ferdousi HA; Dreborg S Clin Exp Allergy; 1997 May; 27(5):530-9. PubMed ID: 9179427 [TBL] [Abstract][Full Text] [Related]
59. Asymptomatic airway hyperresponsiveness: a three-year follow-up. Laprise C; Boulet LP Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 1):403-9. PubMed ID: 9279216 [TBL] [Abstract][Full Text] [Related]